Potential medication dosing errors in outpatient pediatrics

Heather A McPhillips1, Christopher J Stille, David Smith

  • 1Department of Pediatrics and Epidemiology, University of Washington, and the Center for Health Studies, Group Health Cooperative, Seattle, Washington, 98105, USA. heather.mcphillips@seattlechildrens.org

The Journal of Pediatrics
|December 17, 2005
PubMed

Insights

Approximately 15% of children receive medications with potential dosing errors, including overdoses and underdoses. Further research is needed to understand the clinical impact and develop prevention strategies for pediatric medication safety.

Area of Science:

  • Pediatric Pharmacology
  • Medication Safety
  • Health Services Research

Background:

  • Medication dosing errors in children can lead to adverse health outcomes.
  • Accurate medication dispensing is crucial for pediatric patient safety.

Purpose of the Study:

  • To determine the prevalence of potential medication dosing errors in children.
  • To assess dosing errors for 22 common pediatric medications.

Main Methods:

  • Analysis of automated pharmacy data from 3 health maintenance organizations (HMOs).
  • Inclusion of 1933 pediatric subjects with new dispensing prescriptions.
  • Comparison of error rates between paper and electronic prescription systems.

Main Results:

  • 15% of children received medications with potential dosing errors (8% overdose, 7% underdose).
  • Children under 35 kg had only 67% of doses within recommended ranges.
  • Analgesics were most frequently overdosed (15%), while antiepileptics were most underdosed (20%).
  • Electronic prescribing did not reduce error rates.

Conclusions:

  • Potential medication dosing errors are common in outpatient pediatric settings.
  • Further studies are required to evaluate the clinical significance of these errors.
  • Effective strategies for preventing pediatric medication dosing errors need to be developed.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...